Researchers at the Bellvitge Biomedical Research Institute (IDIBELL), led by Oscar Martínez Tirado participated in an international study which suggests inhibition of Sirtuin1 (SIRT1) protein as a future treatment option for metastatic Ewing sarcoma. The results of the study have been published in the journal Cancer Research.

Carolina Garcia-Vidal, researcher at the Infections of the Respiratory Tract and in Immunocompromised Patients research group at IDIBELL and at the infectious diseases unit at the University Hospital of Bellvitge has been unanimously chosen Young Investigator Award for Research in Clinical Microbiology and Infectious Diseases.